[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20000446D0 - Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser - Google Patents

Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser

Info

Publication number
NO20000446D0
NO20000446D0 NO20000446A NO20000446A NO20000446D0 NO 20000446 D0 NO20000446 D0 NO 20000446D0 NO 20000446 A NO20000446 A NO 20000446A NO 20000446 A NO20000446 A NO 20000446A NO 20000446 D0 NO20000446 D0 NO 20000446D0
Authority
NO
Norway
Prior art keywords
physiologically acceptable
complexes
salts
vanadium compounds
acceptable vanadium
Prior art date
Application number
NO20000446A
Other languages
English (en)
Other versions
NO20000446L (no
Inventor
Conradus Ghosal Gho
Original Assignee
Gho St Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gho St Holding Bv filed Critical Gho St Holding Bv
Publication of NO20000446D0 publication Critical patent/NO20000446D0/no
Publication of NO20000446L publication Critical patent/NO20000446L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO20000446A 1997-07-29 2000-01-28 Anvendelse av fysiologisk akseptable vanadiumforbindelser, - salter og -komplekser NO20000446L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1006681A NL1006681C2 (nl) 1997-07-29 1997-07-29 Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.
PCT/NL1998/000431 WO1999006056A1 (en) 1997-07-29 1998-07-29 Use of physiologically acceptable vanadium compounds, salts and complexes

Publications (2)

Publication Number Publication Date
NO20000446D0 true NO20000446D0 (no) 2000-01-28
NO20000446L NO20000446L (no) 2000-03-24

Family

ID=19765422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000446A NO20000446L (no) 1997-07-29 2000-01-28 Anvendelse av fysiologisk akseptable vanadiumforbindelser, - salter og -komplekser

Country Status (22)

Country Link
US (2) US6579540B1 (no)
EP (1) EP1001792B1 (no)
JP (1) JP2001511454A (no)
CN (1) CN1104244C (no)
AT (1) ATE253373T1 (no)
AU (1) AU738701B2 (no)
BR (1) BR9811298A (no)
CA (1) CA2298645C (no)
CZ (1) CZ299716B6 (no)
DE (1) DE69819514T2 (no)
DK (1) DK1001792T3 (no)
EA (1) EA002574B1 (no)
ES (1) ES2207851T3 (no)
ID (1) ID24870A (no)
IL (2) IL134259A0 (no)
NL (1) NL1006681C2 (no)
NO (1) NO20000446L (no)
NZ (1) NZ502613A (no)
PL (1) PL338415A1 (no)
PT (1) PT1001792E (no)
TR (1) TR200000349T2 (no)
WO (1) WO1999006056A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.
US8192994B2 (en) * 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
WO2001045716A1 (en) * 1999-12-20 2001-06-28 Gho'st Holding B.V. Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
ES2485384T3 (es) 2007-01-31 2014-08-13 Basf Plant Science Gmbh Plantas que tienen rasgos potenciados relacionados con el rendimiento y/o mayor resistencia al estrés abiótico y un procedimiento para fabricar las mismas
EP2228386B1 (en) 2007-05-03 2015-03-18 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
US8697947B2 (en) 2007-07-20 2014-04-15 Basf Plant Science Gmbh Plants having increased yield-related traits and a method for making the same
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
CA2703827A1 (en) 2007-10-29 2009-05-07 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
US20110061134A1 (en) 2008-05-05 2011-03-10 Basf Plant Science Gmbh Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
US20100078320A1 (en) * 2008-09-26 2010-04-01 Applied Materials, Inc. Microwave plasma containment shield shaping
JP5878477B2 (ja) 2010-01-15 2016-03-08 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 骨の治癒を加速するためのバナジウム化合物の使用
CN103781358A (zh) 2010-12-10 2014-05-07 新泽西医科和牙科大学 涂布有胰岛素模拟剂复合材料的可植入装置及其方法
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
CN114177197A (zh) * 2011-03-07 2022-03-15 Cfm医药控股有限公司 用于维持哺乳动物体内血糖量正常的钒化合物的用途
US9931348B2 (en) * 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
NL2019605B1 (en) * 2017-09-22 2019-03-28 Cfm Pharma Holding B V Vanadyl and vanadate for use in reducing stress-induced metabolic derangement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012563A1 (en) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Also Published As

Publication number Publication date
US6579540B1 (en) 2003-06-17
TR200000349T2 (tr) 2000-09-21
NL1006681C2 (nl) 1999-02-08
DE69819514T2 (de) 2004-09-23
ATE253373T1 (de) 2003-11-15
CA2298645A1 (en) 1999-02-11
CN1104244C (zh) 2003-04-02
CZ299716B6 (cs) 2008-10-29
CA2298645C (en) 2004-05-18
IL134259A0 (en) 2001-04-30
PL338415A1 (en) 2000-11-06
NZ502613A (en) 2001-08-31
DK1001792T3 (da) 2004-01-19
EP1001792A1 (en) 2000-05-24
ID24870A (id) 2000-08-31
DE69819514D1 (de) 2003-12-11
AU8650598A (en) 1999-02-22
BR9811298A (pt) 2000-08-29
ES2207851T3 (es) 2004-06-01
WO1999006056A1 (en) 1999-02-11
JP2001511454A (ja) 2001-08-14
AU738701B2 (en) 2001-09-27
EA002574B1 (ru) 2002-06-27
EA200000176A1 (ru) 2000-10-30
EP1001792B1 (en) 2003-11-05
NO20000446L (no) 2000-03-24
US20030211170A1 (en) 2003-11-13
CN1270525A (zh) 2000-10-18
CZ2000326A3 (cs) 2000-07-12
PT1001792E (pt) 2004-03-31
IL134259A (en) 2010-02-17

Similar Documents

Publication Publication Date Title
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
MX9707453A (es) Derivados de quinazolina.
WO2003009838A1 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
SE9802208D0 (sv) Novel compounds
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
SE9802209D0 (sv) Novel compounds
CA2385755A1 (en) Prevention of colorectal cancer
WO2001016096A3 (de) Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie
AU3401093A (en) Therapeutic agent for threatened abortion
CA2394471A1 (en) External preparation for treating pruritus
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
MY132436A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
GR20010100390A (el) Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων.
WO2001045717A3 (en) Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
MXPA03010920A (es) Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia.
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application